• 10x Genomics director Shehnaaz Suliman sold 5,723 shares of Class A common stock on June 16, 2026.
• Weighted average sale prices of USD 32.59, USD 33.27.
• Direct holdings fell to 31,722 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001610717-26-000242), on June 18, 2026, and is solely responsible for the information contained therein.